CytoVeris is developing AI-powered cancer imaging technology that can deliver real-time cancer tissue visualization, enabling more precise intraoperative decisions and improving patient outcomes
OncoSIGHT AI™ is a proprietary, next generation tissue characterization algorithm that provides a safer, smarter and more reliable visualization of tissue indicative of cancer. cancerous tissue.
>> CLICK HERE TO LEARN MORE ABOUT ONCOSIGHT AI
Indication
Pre-clinical research
Feasibility Study
Pivotal Study
FDA Approval
TumorMAP Technology
Visualizing Tissue Type, Cancer Boundaries, and Critical Structures Intraoperatively without Dyes
TumorMAP™ quickly identifies tissue/disease state based on its intrinsic/endogenous biomolecular characteristics
It can be applied to all solid tumor cancers and other target tissue types
TumorMAP™ powered by OncoSIGHT AI™ relies on the intersection of the natural biochemical characteristics of tissue, multispectral imaging and AI, and is under development to make a difference for patients across multiple disease areas.
TISSUE SPECIMEN
MULTI-SPECTRAL UV AUTOFLUORESCENCE
IMAGING
AI-POWERED TISSUE ANALYSIS
TARGET TISSUE IDENTIFICATION
Digital Surgery is Driving a Cultural Change
CytoVeris’ proprietary algorithm, OncoSIGHT AI™ will make surgery smarter and safer for surgeons and patients – no matter who they are or where they live! OncoSIGHT AI™ will empower surgeons to make critical decisions in real-time to achieve optimal results during a cancer resection.
Real-time visual data insights
Democratizing surgical visualization
Procedure Adaptability